DexCom Inc. Files Q1 2025 10-Q
Ticker: DXCM · Form: 10-Q · Filed: 2025-05-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
Related Tickers: DXCM
TL;DR
DexCom's Q1 2025 10-Q is in, showing their latest financial health. **#DXCM**
AI Summary
DexCom Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and balance sheet information are presented, reflecting the company's ongoing activities in the medical device sector.
Why It Matters
This filing provides investors and analysts with the latest financial snapshot of DexCom, a key player in continuous glucose monitoring technology, impacting its stock valuation and future investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate or unusual risk factors highlighted.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Marks the end of the financial quarter being reported.)
- 2025-05-01 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2025-01-01 — Reporting Period Start Date (Marks the beginning of the financial quarter.)
Key Players & Entities
- DexCom Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250501 (date) — Filing date
- SAN DIEGO (location) — Company headquarters city
- DE (location) — State of incorporation
FAQ
What is the primary business of DexCom Inc.?
DexCom Inc. is primarily involved in the 'Surgical & Medical Instruments & Apparatus' industry, SIC code 3841.
For what period is this 10-Q report filed?
This 10-Q report is for the period ending March 31, 2025.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on May 1, 2025.
What is the company's state of incorporation?
DexCom Inc. is incorporated in Delaware (DE).
Where is DexCom Inc. headquartered?
The company's business and mailing address is in San Diego, California (CA).
From the Filing
0001093557-25-000113.txt : 20250501 0001093557-25-000113.hdr.sgml : 20250501 20250501171534 ACCESSION NUMBER: 0001093557-25-000113 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 76 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 25904360 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 10-Q 1 dxcm-20250331.htm 10-Q dxcm-20250331 false 2025 Q1 0001093557 12/31 0.0061571 0.006662 367 366 364 365 456 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure dxcm:trading_day dxcm:segment dxcm:primary_market 0001093557 2025-01-01 2025-03-31 0001093557 2025-04-24 0001093557 2025-03-31 0001093557 2024-12-31 0001093557 2024-01-01 2024-03-31 0001093557 us-gaap:CommonStockMember 2024-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001093557 us-gaap:RetainedEarningsMember 2024-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2024-12-31 0001093557 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001093557 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001093557 us-gaap:CommonStockMember 2025-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001093557 us-gaap:RetainedEarningsMember 2025-03-31 0001093557 us-gaap:TreasuryStockCommonMember 2025-03-31 0001093557 us-gaap:CommonStockMember 2023-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001093557 us-gaap:RetainedEarningsMember 2023-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2023-12-31 0001093557 2023-12-31 0001093557 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001093557 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001093557 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001093557 us-gaap:CommonStockMember 2024-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001093557 us-gaap:RetainedEarningsMember 2024-03-31 0001093557 us-gaap:TreasuryStockCommonMember 2024-03-31 0001093557 2024-03-31 0001093557 srt:MinimumMember 2025-01-01 2025-03-31 0001093557 srt:MaximumMember 2025-01-01 2025-03-31 0001093557 dxcm:CollaborativeSalesBasedMilestoneMember 2025-01-01 2025-03-31 0001093557 dxcm:CollaborativeSalesBasedMilestoneMember 2024-01-01 2024-03-31 0001093557 dxcm:RestrictedAndPerformanceStockUnitsMember 2025-01-01 2025-03-31 0001093557 dxcm:RestrictedAndPerformanceStockUnitsMember 2024-01-01 2024-03-31 0001093557 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-03-31 0001093557 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-03-31 0001093557 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001093557 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001093557 us-gaap:FairValueInputsLevel1Member 2025-03-31 0001093557 us-gaap:FairValueInputsLevel2Member 2025-03-31 0001093557 us-gaap:FairValueInputsLevel3Member 2025-03-31 0001093557 us-gaap:FairValueInputsLevel1Member us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember 2025